Company: MDCXW
Filing Date: 2025-06-30
Form Type: DEF 14A
Source: 0001062993-25-012273
Chunk: 53

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: DEF 14A
Chunk 53
---
 sets out the Governance Committee's responsibilities, including:

periodically reviewing and assessing the mandate adopted by the Board and recommending any amendments to the Board

periodically reviewing and assessing the mandate of each committee of the Board and recommending any amendments to the Board

reviewing and assessing the position descriptions for, as such positions may exist from time to time, the Lead Independent Director, Executive Chairman or Chairman of the Board, the Chair of the Audit Committee and the Chair of this Committee and recommending any amendments to the Board;

periodically reviewing and assessing the Company's policies and recommending any amendments to the Board;

reviewing and recommending the implementation of structures and procedures to facilitate the Board's independence and the independence of its members from management and to avoid conflicts of interest;

reviewing, approving and overseeing any transaction or agreement in which a director or senior management has a material interest;

developing and recommending to the Board for approval a corporate code of conduct for all employees (including senior officers), monitoring compliance with such code, investigating any alleged breach or violation of such code, enforcing the provisions of such code, and reviewing such code periodically and recommending any changes to the Board;

working with the CEO and other members of senior management to foster a healthy governance culture within the Company;

monitoring the compliance by the Company with other statutory and regulatory requirements applicable to the Company; and

monitoring developments in the area of governance and recommend initiatives that will help the Company maintain high standards of governance.

A copy of the Governance Committee Charter is available on our corporate website at www.medicuspharma.com/corporate-govenance/.

Corporate Disclosure Committee

The Corporate Disclosure Committee consists of William Ashton, Dr. Raza Bokhari and Robert Ciaruffoli, with Mr. Ciaruffoli serving as chairman. The Corporate Disclosure Committee is responsible for assisting the Company's management in (i) determining whether information is material information; (ii) ensuring the timely disclosure of such material information in accordance with applicable securities laws; and (iii) overseeing the disclosure controls, procedures and practices of the Company.

Communications from Shareholders

Shareholders and other interested parties who wish to communicate with the Chair of the Board, the independent or non-management directors, or the Board as a whole, should address such communications to the applicable party or parties and send via e-mail: ir@medicuspharma.com. The Company will review all incoming communications and forward such communications to the appropriate member(s) of the Board. The Company will generally not forward communications that are unrelated to the duties and responsibilities